Tumor scanner TM900

Tumor scanner TM900

Manufacturer: 

Peira's TM900 is an innovative, non-invasive, accurate and easy to use handheld device for measuring tumor volume in subcutaneuous mouse xenografts in vivo.

Add to quote request
  • Description
  • Publications
  • References

Tumor scanner TM900

TM900 is a complete platform; besides the handled device, the TM900 comes with a touch screen panel PC with the measurement software.
The measurement software allows visualizing the tumor topography and the analyzed surface.
 Important tumor features such as height, width, depth and volume are automatically calculated. Previous measurements of the animals are shown on the screen to allow instantaneous folllow-up of tumore volume over tie. The software interface also allows coupling with other hardware such as balances, RFID scanners, ... to allow for complementary measurements. An export function is foreseen to export the data to the management software for further ananlysis.

The management software allows for a complete data management of your data; you can defne experiments, assign animals to groups (randomization), visualize and reanalyze the tumors and make plots of the data. Export to e.g. exel is foreseen.

Whay the TM900?

  • Visualization in 3D of the tumor topography. This allows for visual inspection of the tumor shape and morphology over time and flagging of the necrotic or inflamed tumors.

  • Data integrity and traceability. The software allow for storage, ananlysis, visualization and management of the data, which is essential for robust data follow-up and QA-requirements

  • Validation. High resolution 3D images are acquired, allowing precise volume estimations and validation of the measured surface. Especially oddly shaped or thin tumors benefit from TM900 volume estimations.

Watch more

Specification

Measurement range (X - Y) 25 mm - 25 mm
Maximum tumor size (L x W x H) 20 mm x 20 mm x 20 mm
Accuracy per measured 3D point < 0,3 mm
Stereo capture time ~ 0,1 s
Device, panel-pc interface USB 2.0
Camera 1600 x 1200 pixel (2 MP)
Projector 300 x 300 pixels, 532 nm
(green for optimal contrast)
Camera/projector working distance 50 mm

 

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.

Science. 2017 Jan 6;355(6320):84-88. doi: 10.1126/science.aah4307.

Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen CC, Wongvipat J, Ku SY, Gao D, Cao Z, Shah N, Adams EJ, Abida W, Watson PA, Prandi D, Huang CH, de Stanchina E, Lowe SW, Ellis L, Beltran H, Rubin MA, Goodrich DW, Demichelis F, Sawyers CL.

•    City University of Hong Kong
•    Hunter College, CUNY*
•    Vanderbilt University Medical Center*
•    Hainan Medical University*
•    Howard Hughes Medical Institute*
•    Memorial Sloan Kettering Cancer Center*
•    Cancer Center Amsterdam
•    GlaxoSmithKline
•    Imec
•    K.U.Leuven
•    Neuro-Electronics Research Flanders

•    Pepric
•    PharmaVize
•    reMYND
•    University Ghent
•    SEPS Pharma
•    Vlaams Instituut voor Biotechnologie
•    University Antwerp
•    ThromboGenics
•    Janssen Pharmaceutica